This concurrent resolution objects to the slowdown in mail delivery instituted by the Postmaster General and urges that the decisions to slow down mail and increase postage rates be halted immediately pending further investigation and full substantiation by the Postmaster General to Congress.
This resolution condemns Belarusian authorities' assault on freedom of expression and human rights in Belarus since the August 2020 presidential election. The resolution also calls for the immediate release of journalists, cultural figures, and dissidents currently held as political prisoners in Belarus. Furthermore, the resolution calls on the Biden Administration to support initiatives to assist survivors of torture and other human rights violations from Belarus, including by working with allies in the region to grant them protection and providing avenues for them and their families to access safety in the United States; examine all available accountability options for violators of human rights and fundamental freedoms; and demand that Belarus cooperate fully with international partners and organizations, including the United Nations High Commissioner for Human Rights. Finally, the resolution supports the aspirations of the Belarusian people in their struggle for freedom and human rights.
This resolution commemorates the 70th anniversary of the security treaty between Australia, New Zealand, and the United States and reaffirms the U.S. commitments under the treaty. It also supports new opportunities to deepen and broaden security relations and economic ties between the three countries.
This resolution applauds Kazakhstan's 30-year commitment to nuclear nonproliferation and disarmament. It also recognizes that Kazakhstan has committed to strengthening the U.S.-Kazakhstan relationship by working on issues such as keeping the world safe from nuclear weapons.
Stop Penalizing Working Seniors Act This bill allows Medicare-eligible individuals who are age 65 or older to contribute to health savings accounts if their entitlement to Medicare benefits is limited to hospital insurance benefits under Medicare Part A.
HR 5553 prohibits the Secretary of Veterans Affairs from providing or paying for surgical treatments related to gender transition. This directly affects transgender veterans who rely on VA healthcare for gender-affirming surgical procedures. The bill blocks VA funding specifically for these surgical treatments, without altering coverage for other healthcare services. It applies to all veterans seeking such care through the VA system.
United States–Israel Artificial Intelligence Center Act This bill requires the Department of State to establish the United States–Israel Artificial Intelligence Center to leverage the experience, knowledge, and expertise of institutions of higher education and private sector entities in the United States and Israel to develop more robust research and development cooperation in specified areas (e.g., machine learning, object detection, and speech recognition).
Small Business Advanced Cybersecurity Enhancements Act of 2021 This bill requires the Small Business Administration (SBA) to establish a central small business cybersecurity-assistance unit within the SBA and a regional cybersecurity-assistance unit within each small business development center. These units shall serve as the primary means for a small business to communicate cyber threats and defensive measures with the federal government, and the bill prohibits any cause of action against a small business for such communication or for any conduct in response to such communication.
Cosmetic Supply Chain Transparency Act of 2021 This bill requires the Food and Drug Administration (FDA) to maintain a list of certain nonfunctional constituents in cosmetics that are harmful to human health or the environment, authorizes the FDA to request from a brand owner (i.e., the entity bringing a cosmetic to market) certain information about a cosmetic's ingredients, and addresses related issues. For each listed nonfunctional constituent, the list must identify the ingredient or cosmetic (or category of ingredient or cosmetic) in which the constituent is known or reasonably expected to be present. The FDA must also (1) establish procedures for petitions to add substances to the list, (2) issue guidance for industry related to testing and detecting such nonfunctional constituents, and (3) establish a committee to provide advice on creating the list and developing the required industry guidance. Within a year of a nonfunctional constituent being added to the list, a supplier of an ingredient or cosmetic must test for that constituent and provide a brand owner the results and other information before selling the ingredient or cosmetic to the brand owner. A supplier of an ingredient or cosmetic must provide additional information about the item upon a brand owner's request. Brand owners must maintain records with information about the suppliers of ingredients and raw materials used in their cosmetics and provide such information to the FDA upon request. The bill also imposes civil penalties for brand owners and suppliers that violate this bill's provisions.
HR 5537, the Toxic-Free Beauty Act of 2021, bans specific chemicals in cosmetics under federal law. It prohibits the use of substances like certain PFAS (water-repellent chemicals), phthalates (e.g., dibutyl phthalate), formaldehyde, mercury, and specific parabens in cosmetic products. The ban directly affects cosmetic manufacturers, requiring them to reformulate products, and benefits consumers by removing these chemicals from beauty items. The law takes effect on January 1, 2025, with the ban applying to products bearing or containing the listed substances.
Cosmetic Fragrance and Flavor Ingredient Right to Know Act of 2021 This bill imposes disclosure and labeling requirements on cosmetics products that contain certain ingredients. A cosmetics product that fails to meet such requirements may not be sold. Within two years of this bill's enactment, a cosmetics product's labeling or packaging must indicate the use of any ingredient that (1) is identified on specified lists of harmful or potentially harmful chemicals, such as chemicals identified as carcinogenic to humans by the Environmental Protection Agency or toxic air contaminants under California regulations; or (2) must be disclosed under certain European Union laws and is present in a product above specified concentrations. The Food and Drug Administration must publish and periodically update on its website a list of the ingredients subject to this requirement. Within one year of this bill's enactment, a brand owner (i.e., the entity bringing a cosmetics product to market) must disclose certain information on its website if a cosmetics product contains any fragrance or flavor ingredient that is (1) present in the product above a certain concentration, or (2) subject to this bill's labeling or packaging requirement. The website must disclose the use of the ingredient in question and other information, such as the ingredient's functional purpose. The use of an ingredient subject to this bill's requirements shall not be treated as a confidential trade secret, but the concentration of such an ingredient shall be treated as confidential commercial information.
Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2021 This bill imposes labeling requirements on cosmetics intended for professional use, requires research on health issues relating to cosmetics, and addresses related issues. The Food and Drug Administration (FDA) must require (1) the labeling for cosmetics intended for professional use to include the name of each ingredient in descending order of predominance; and (2) the manufacturer, distributor, or seller of such a cosmetic to provide this information on its website. The Occupational Safety and Health Administration must issue a standard requiring each manufacturer or importer selling a cosmetic intended for professional use to (1) obtain or develop a safety data sheet for the cosmetic in various languages; and (2) make the data sheet available to relevant distributors and employers, such as hair salon owners. The standard must also require employers to make the data sheet available to employees exposed to the product and provide to employees versions of the sheet in languages other than English upon request. The FDA must conduct (or award grants for) research into chemicals linked to adverse health effects and most commonly found in cosmetics that are (1) marketed to women and girls of color; or (2) used by professional nail, hair, and beauty salon workers. The FDA must also award grants to support research focused on designing safer cosmetic chemicals, such as those with no inherent toxicity. The FDA must take actions to ensure that cosmetics marketed to women and girls of color are in full compliance with FDA requirements.
